Rizzuto, A.; Pirrera, A.; Gigliotta, E.; Mancuso, S.; Vullo, C.; Camarda, G.M.; Rotolo, C.; Roppolo, A.; Spoto, C.; Gentile, M.;
et al. Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials. Int. J. Mol. Sci. 2023, 24, 9930.
https://doi.org/10.3390/ijms24129930
AMA Style
Rizzuto A, Pirrera A, Gigliotta E, Mancuso S, Vullo C, Camarda GM, Rotolo C, Roppolo A, Spoto C, Gentile M,
et al. Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials. International Journal of Molecular Sciences. 2023; 24(12):9930.
https://doi.org/10.3390/ijms24129930
Chicago/Turabian Style
Rizzuto, Andrea, Angelo Pirrera, Emilia Gigliotta, Salvatrice Mancuso, Candida Vullo, Giulia Maria Camarda, Cristina Rotolo, Arianna Roppolo, Corinne Spoto, Massimo Gentile,
and et al. 2023. "Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials" International Journal of Molecular Sciences 24, no. 12: 9930.
https://doi.org/10.3390/ijms24129930
APA Style
Rizzuto, A., Pirrera, A., Gigliotta, E., Mancuso, S., Vullo, C., Camarda, G. M., Rotolo, C., Roppolo, A., Spoto, C., Gentile, M., Botta, C., & Siragusa, S.
(2023). Molecular-Biology-Driven Frontline Treatment for Chronic Lymphocytic Leukemia: A Network Meta-Analysis of Randomized Clinical Trials. International Journal of Molecular Sciences, 24(12), 9930.
https://doi.org/10.3390/ijms24129930